Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 5/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.44 |
| ▸ | TACR2 | P21452 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | SHBG | P04278 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15064834 | 1.00 | PTGS2 (0.53) | PTGS2CYP3A4GAAKMT2AESR1 | |
| SCHEMBL17781753 | 1.00 | PTGS2 (0.53) | PTGS2CYP3A4GAAKMT2AESR1 | |
| SCHEMBL11188772 | 1.00 | PTGS2 (0.53) | PTGS2CYP3A4GAAKMT2AESR1 | |
| SCHEMBL15065758 | 0.98 | PTGS2 (0.52) | PTGS2CYP3A4GAAKMT2AESR1 | |
| SCHEMBL5151481 | 0.91 | PTGS2 (0.58) | PTGS2CYP3A4GAAKMT2AESR1 | |
| SCHEMBL421859 | 0.91 | PTGS2 (0.58) | PTGS2CYP3A4GAAKMT2AESR1 | |
| SCHEMBL423476 | 0.91 | PTGS2 (0.58) | PTGS2CYP3A4GAAKMT2AESR1 | |
| SCHEMBL225812 | 0.91 | PTGS2 (0.58) | PTGS2CYP3A4GAAKMT2AESR1 | |
| SCHEMBL222426 | 0.91 | PTGS2 (0.58) | PTGS2CYP3A4GAAKMT2AESR1 | |
| SCHEMBL426302 | 0.91 | PTGS2 (0.58) | PTGS2CYP3A4GAAKMT2AESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0509740-B1 | Heat-developable photosensitive material and image forming method making use of the heat-developable photosensitive material | CANON KK (JP) | 1996-06-26 | — | — | EP | claimed |
| EP-2797938-B1 | METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN | BASF SE (DE) | 2016-06-01 | — | — | EP | disclosed |
| EP-2797938-A1 | METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN | BASF SE (DE) | 2014-11-05 | — | — | EP | disclosed |
| US-8841474-B2 | Process for preparing 6-chlorodibenzo[D,F][1,3,2]dioxaphosphepin | BASF SE (DE) | 2014-09-23 | — | — | US | disclosed |
| WO-2013098371-A1 | METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN | BASF SE (DE) | 2013-07-04 | — | — | WO | disclosed |
| US-20130172596-A1 | PROCESS FOR PREPARING 6-CHLORODIBENZO[D,F][1,3,2]DIOXAPHOSPHEPIN | BASF SE (DE) | 2013-07-04 | — | — | US | disclosed |
| EP-0509740-B1 | Heat-developable photosensitive material and image forming method making use of the heat-developable photosensitive material | CANON KK (JP) | 1996-06-26 | — | — | EP | disclosed |
| US-5262295-A | Biphenyldihydroxide reducing agent for silver halide emulsion layers | CANON KABUSHIKI KAISHA (JP) | 1993-11-16 | — | — | US | disclosed |
| EP-0509740-A1 | Heat-developable photosensitive material and image forming method making use of the heat-developable photosensitive material | CANON KABUSHIKI KAISHA (JP) | 1992-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172596-A1 | PROCESS FOR PREPARING 6-CHLORODIBENZO[D,F][1,3,2]DIOXAPHOSPHEPIN | DCPS, PLCB3, DDT | PTGS2 3425/4885CYP3A4 628/4885GAA 2245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.